The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study-Reference-Cited by-同舟云学术

The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study

Published:2018-08 Issue:4 Volume:28 Page:333-340
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Ascierto Paolo A.,Bastholt Lars,Ferrucci Pier F.,Hansson Johan,Márquez Rodas Iván,Payne Miranda,Robert Caroline,Thomas Luc,Utikal Jochen S.,Wolter Pascal,Kudlac Amber,Tuson Harriet,McKendrick Jan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference7 articles.

1. Advances in immunotherapy for melanoma;Redman;BMC Med,2016

2. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline-Update 2012;Garbe;Eur J Cancer,2012

3. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Dummer;Ann Oncol,2015

4. Malignant melanoma S3-guideline ‘diagnosis, therapy and follow-up of melanoma’;Pflugfelder;J Dtsch Dermatol Ges,2013

5. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma;International Journal of Molecular Sciences;2024-01-31

2. Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015–2018 in Greece. The ‘SUMMER’ study: a retrospective multicenter chart review project;Melanoma Research;2023-12-13

3. Melanome der Haut und Schleimhaut;Medikamentöse Tumortherapie von Kopf-Hals-Tumoren;2022

4. New systemic therapies for cutaneous melanoma: why, who and what;Italian Journal of Dermatology and Venereology;2021-07

5. Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition;European Journal of Cancer;2021-05